FINWIRES · TerminalLIVE
FINWIRES

道達爾能源完成EPH電力資產的收購,推動菲律賓太陽能項目

By

-- 道達爾能源(TotalEnergies)週四宣布,已完成對EPH西歐靈活發電平台50%股權的收購,由此成立了TTEP,成為歐洲第二大靈活發電企業。 這家法國能源巨頭表示,總部位於阿姆斯特丹的TTEP在義大利、英國、愛爾蘭、荷蘭和法國擁有約14吉瓦的已安裝或在建裝置容量。 TTEP的業務組合包括天然氣、生質能和電池儲能係統資產,預計2025年將生產近30太瓦時的電力。 該平台還擁有約5吉瓦的在建項目,使其成為西歐靈活發電和大規模電池儲能擴張的關鍵平台。 根據協議,道達爾能源和EPH將透過與TTEP簽訂代銷合同,銷售各自份額的電力。 作為交易的一部分,道達爾能源向EPH發行了約9,540萬股股票,約佔其股本的4.2%。 此外,道達爾能源宣布已完成融資,並與合作夥伴Nextnorth在菲律賓啟動一個440兆瓦的太陽能專案建設。 該項目位於伊莎貝拉省伊拉甘市,投資額達3億美元,道達爾能源持有65%的股份,Nextnorth持有35%的股份,預計將於2027年底投入營運。在20年的營運期內,該項目預計將發電約13.5太瓦時。 超過一半的電力將根據長期協議出售給零售電力供應商AdventEnergy和PrimeRES,剩餘部分將透過政府的綠色能源拍賣計畫輸送至國家電網。

Price: $93.10, Change: $+0.86, Percent Change: +0.93%

Related Articles

Sectors

Sector Update: Financial

Financial stocks were higher late Thursday afternoon, with the NYSE Financial Index rising 1.3% and the State Street Financial Select Sector SPDR ETF (XLF) up 0.5%.The Philadelphia Housing Index climbed 1.6%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) added 1.5%.Bitcoin (BTC-USD) rose 0.9% to $76,409, and the yield for 10-year US Treasuries decreased 2.8 basis points to 4.39%.In corporate news, AvalonBay Communities (AVB) and Equity Residential (EQR) have held discussions over a potential merger, which would be one of the biggest real estate deals ever, Bloomberg reported. AvalonBay shares were down 1.1%, and Equity Residential was fractionally lower.

$AVB$EQR
Australia

Market Chatter: Zuckerberg, Cook Not Exploring Seattle Seahawks Bid

Meta Platforms (META) CEO Mark Zuckerberg and Apple (AAPL) CEO Tim Cook are not pursuing a bid for the National Football League's Seattle Seahawks, Bloomberg reported on Thursday, citing company and industry sources.A Meta spokesperson said Zuckerberg is not making any investment or bid for the team, while a person familiar with Cook's plans denied his involvement, the report said.Meta and Apple did not immediately respond to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $616.43, Change: $-52.69, Percent Change: -7.87%

$AAPL$META
Australia

Axsome Therapeutics Says FDA Approves Auvelity for Alzheimer's Disease Agitation

Axsome Therapeutics (AXSM) said Thursday the US Food and Drug Administration approved Auvelity for the treatment of agitation associated with Alzheimer's disease dementia.The approval was supported by two phase 3 clinical trials that showed the drug significantly improved agitation symptoms and resulted in a longer time to relapse compared with placebo.The medication acts on N-methyl-D-aspartate and sigma-1 receptors in the brain and is also approved for adults with major depressive disorder, the company added.Shares of Axsome were up more than 12% in Thursday trading.Price: $206.45, Change: $+22.50, Percent Change: +12.23%

$AXSM